A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
Public ClinicalTrials.gov record NCT03374917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 for up to 4 Weeks in an Outpatient Environment
Study identification
- NCT ID
- NCT03374917
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- ABBV-951 Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 17, 2018
- Primary completion
- Mar 3, 2019
- Completion
- Mar 3, 2019
- Last update posted
- Nov 11, 2024
2018 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner Sun Health Res Inst /ID# 165840 | Sun City | Arizona | 85351 | — |
| Loma Linda University /ID# 165592 | Loma Linda | California | 92354 | — |
| Univ CA, Irvine Med Ctr /ID# 165594 | Orange | California | 92868 | — |
| Compass Research /ID# 167329 | Orlando | Florida | 32806 | — |
| Univ Kansas Med Ctr /ID# 166280 | Kansas City | Kansas | 66160 | — |
| University of Kentucky Chandler Medical Center /ID# 164407 | Lexington | Kentucky | 40536 | — |
| University of Louisville /ID# 164997 | Louisville | Kentucky | 40202 | — |
| Washington University-School of Medicine /ID# 164412 | St Louis | Missouri | 63110 | — |
| NYU Langone Medical Center /ID# 164924 | New York | New York | 10016-6402 | — |
| University of Cincinnati /ID# 165142 | Cincinnati | Ohio | 45267-0585 | — |
| Cleveland Clinic Foundation /ID# 164413 | Cleveland | Ohio | 44195 | — |
| Neurology Consultants of Dallas /ID# 167116 | Dallas | Texas | 75251-3831 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03374917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03374917 live on ClinicalTrials.gov.